City of Hope is recognized internationally for its breakthrough treatments for leukemia and other blood disorders. City of Hope is one of the largest transplant centers in the country for the treatment of leukemia and has had some of the consistently best outcomes for the last five years. Designated a Comprehensive Cancer Center by the National Cancer Institute, City of Hope is acknowledged as a leader in cancer research and treatment.
City of Hope is actively pursuing tomorrow’s breakthrough treatments today. We have created new treatment protocols for:
Acute lymphoblastic leukemia (ALL)
Chronic lymphocytic leukemia (CLL)
Hairy Cell Leukemia
Adult T cell leukemia/lymphoma (ATLL)
Acute myeloid leukemia (AML)
Chronic myelogenous leukemia (CML)
City of Hope was one of the pioneers in “mini” hematopoietic cell transplants that allow for transplantation in older patients. We offer the broadest range of therapeutic options available, including protocols developed here at City of Hope and funded in part by the National Institutes of Health. Through ongoing clinical trials, our physicians and researchers continue to lead the way in improving outcomes in leukemia patients.
City of Hope utilizes stem cell transplantation and pioneering approaches such as radioimmunotherapy and adoptive T cell therapy in treating leukemia patients. These methods augment the effectiveness of chemotherapy. In fact, for many patients, a stem cell transplant offers a real chance at curing leukemia rather than just achieving remission.
City of Hope’s acclaimed leadership in stem cell transplantation ensures that patients receive the latest treatment protocols designed to maximize successful transplant engraftment, while minimizing rejection and debilitating side effects. Our many patients who have been cured of leukemia provide a living testament to the expertise of City of Hope physicians.